Literature DB >> 24377925

Endosomal signaling and oncogenesis.

Nikolai Engedal1, Ian G Mills2.   

Abstract

The endosomal system provides a route whereby nutrients, viruses, and receptors are internalized. During the course of endocytosis, activated receptors can accumulate within endosomal structures and certain signal-transducing molecules can be recruited to endosomal membranes. In the context of signaling and cancer, they provide platforms within the cell from which signals can be potentiated or attenuated. Regulation of the duration of receptor signaling is a pivotal means of refining growth responses in cells. In cancers, this is often considered in terms of mutations that affect receptor tyrosine kinases and maintain them in hyperactivated states of dimerization and/or phosphorylation. However, disruption to the regulatory control exerted by the assembly of protein complexes within the endosomal network can also contribute to disease among which oncogenesis is characterized in part by dysregulated growth, enhanced cell survival, and changes in the expression of markers of differentiation. In this chapter, we will discuss the role of proteins that regulate in endocytosis as tumor suppressors or oncogenes and how changing the fate of internalized receptors and concomitant endosomal signaling can contribute to cancer.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adaptor; Cancer; Endocytosis; Growth factor; Signaling

Mesh:

Substances:

Year:  2014        PMID: 24377925     DOI: 10.1016/B978-0-12-397925-4.00012-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  3 in total

1.  GDC-0152-induced autophagy promotes apoptosis in HL-60 cells.

Authors:  Liang Peiqi; Hu Rong; Dong Hongming; Liu Zhuogang; Jiang Wei; Miao Miao
Journal:  Mol Cell Biochem       Date:  2018-01-03       Impact factor: 3.396

2.  RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development.

Authors:  Direna Alonso-Curbelo; Lisa Osterloh; Estela Cañón; Tonantzin G Calvo; Raúl Martínez-Herranz; Panagiotis Karras; Sonia Martínez; Erica Riveiro-Falkenbach; Pablo-Ortiz Romero; José Luis Rodríguez-Peralto; Joaquín Pastor; María S Soengas
Journal:  Oncotarget       Date:  2015-05-20

3.  ERBB1- and ERBB2-Positive Medullary Thyroid Carcinoma: A Case Report.

Authors:  Michele Minuto; Emanuela Varaldo; Gianluca Marcocci; Amleto de Santanna; Ermanno Ciccone; Katia Cortese
Journal:  Diseases       Date:  2018-04-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.